Question · asked by 1 review
Conjugated oral oestrogens vs transdermal 17ß‐estradiol: Adverse events
- Population
- girls with Turner syndrome who were treated with prepubertal growth hormone
- Intervention
- Conjugated oral oestrogens
- Comparison
- transdermal 17ß‐estradiol
- Outcome
- Adverse events
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Conjugated oral oestrogens vs transdermal 17ß‐estradiol Adverse events · girls with Turner syndrome who were treated with prepubertal growth hormone The review found no eligible studies for this question. Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.